BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Atezolizumab
1
Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies
12/12/2024 7:29:58 AM | Browse: 117 | Download: 499
2
Downstaging of advanced hepatocellular carcinoma followed by liver transplantation using immune checkpoint inhibitors: Where do we stand?
9/3/2024 8:54:07 AM | Browse: 134 | Download: 466
3
Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report
7/2/2024 8:41:38 AM | Browse: 140 | Download: 734
4
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
3/27/2024 1:28:19 PM | Browse: 141 | Download: 411
5
Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report
6/15/2023 12:09:46 PM | Browse: 390 | Download: 1145
6
Acute respiratory distress syndrome and severe pneumonitis after atezolizumab plus bevacizumab for hepatocellular carcinoma treatment: A case report
5/12/2023 9:13:35 AM | Browse: 464 | Download: 1129
7
Systemic treatment for unresectable hepatocellular carcinoma
3/10/2023 7:29:15 AM | Browse: 313 | Download: 933
8
New perspectives in the management of small cell lung cancer
6/22/2022 8:29:42 AM | Browse: 559 | Download: 1332
9
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
9/22/2021 8:09:41 AM | Browse: 670 | Download: 1121
10
Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report
5/14/2021 9:21:56 AM | Browse: 654 | Download: 1935
11
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
1/16/2020 7:58:40 AM | Browse: 1014 | Download: 2019
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345